We are a ventured backed HealthTech company that designed, clinically validates and commercialize our products. Our aim is to identify and prioritize unaddressed chronic neurological conditions that constitute significant market opportunities and add value to the existing Healthcare system.
We manufacture our own product which is FDA regulated Class II 510(k) medical device - BRS Biofeedback combines with our proprietary HealthTech- Reverse Hearing Loss and Non Surgical Correction of Joint deformities, we are going to roll out a platform to match the TET (Tinnitus Elimination Trainee) with the millions of Tinnitus sufferers in major cities.
We have designed a proprietary platform for the delivery of the non invasive novel treatment for chronic neurological conditions and we are currently focusing on development of Treatment for chronic Tinnitus, an unaddressed clinical condition commonly known as "Ringing in the ear".
Tinnitus currently affect 1 in 10 adults and severely impact 1% of the general population.
Our tech is positioned to meet the unmet clinical needs of the millions of Tinnitus sufferers globally.
Tinnitus is age related with the risk of developing the condition doubling over the age of 50.
Tinnitus is related to acute prolonged noise exposure. The use of personal entertainment device in the 80's is the predisposing factor of getting Tinnitus and this batch of population is now in their 50's.
Tinnitus remains a stubbornly untreatable chronic condition that constitutes a significant economic burden to the society and the public healthcare system globally. This recurring problem has become a crisis just second worse to the opioid crisis in pain management.